Physician profile
Milton A Jimenez
NPI 1437148384
$6,179.39
in general payments reported to CMS, 2019-2025
17 companies · $497 in 2025
The $497 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,647 · 2020: $402 · 2021: $746 · 2022: $853 · 2023: $550 · 2024: $485 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,531.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,053.54 | 2019-2024 | Gallant, Aveir |
| Impulse Dynamics (USA) INC. | $1,177.32 | 2021-2025 | Optimizer, Optimizer |
| Biotronik INC. | $909.83 | 2019-2020 | |
| Medtronic Vascular, INC. | $377.42 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $310.22 | 2019-2025 | Ofev |
| Vifor Pharma, INC. | $218.94 | 2019 | |
| Pfizer INC. | $195.60 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $187.56 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $148.48 | 2019-2021 | |
| Medtronic, INC. | $123.68 | 2021 | |
| Metuchen Pharmaceuticals | $118.72 | 2019 | |
| Sunovion Pharmaceuticals INC. | $110.75 | 2019 | |
| Lilly USA, LLC | $81.63 | 2019-2023 | Mounjaro |
| Janssen Pharmaceuticals, INC | $80.59 | 2019-2020 | |
| Novo Nordisk INC | $45.20 | 2024 | Rybelsus, Ozempic |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $25.30 | 2023 | Adlarity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milton Jimenez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.